Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry)

Yerel katalogda bu makaleye atıf yapan 24 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

1. 2023 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidanceAtıf 364 · OpenAlex
2. 2023 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidanceAtıf 357 · OpenAlex
3. 2022 Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort studyAtıf 216 · OpenAlex
4. 2022 Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort studyAtıf 215 · OpenAlex
5. 2021 Familial Hypercholesterolemia: Global Burden and ApproachesAtıf 88 · OpenAlex
6. 2021 Collateral damage of the COVID-19 pandemic on the management of homozygous familial hypercholesterolemiaAtıf 88 · OpenAlex
7. 2021 LDL Apheresis and Lp (a) Apheresis: A Clinician’s PerspectiveAtıf 43 · OpenAlex
8. 2024 Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPNAtıf 27 · OpenAlex
9. 2022 Current Treatment Options in Homozygous Familial HypercholesterolemiaAtıf 22 · OpenAlex
10. 2022 Current Treatment Options in Homozygous Familial HypercholesterolemiaAtıf 22 · OpenAlex